Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Aug 8, 2023, after the close
10-Q filed Aug 8, 2023, 39 days after period end · 0000950170-23-039899
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $49.69M | $40.16M | $30.41M | $19.14M |
| Net Income | -$4.39M | -$702.00K | $2.67M | $8.11M |
| EPS Diluted |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
| -$0.03 |
| $0.00 |
| $0.00 |
| $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.